Diagnostic performance, implementation fidelity, and costs of the World Health Organization three-test HIV testing strategy in Malawi: a national retrospective evaluation
A national retrospective evaluation in Malawi demonstrates that transitioning to the WHO-recommended three-test HIV strategy effectively prevented false-positive diagnoses and unnecessary antiretroviral therapy at a modest incremental cost, thereby supporting the broader adoption of this guidance in similar settings.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
In many parts of the world, doctors rely on quick, affordable tests to find out if a person has HIV, the virus that causes AIDS. These tests are designed to be used in clinics and even in remote villages, giving immediate answers so people can start treatment or receive prevention advice right away. Because no test is perfect, the standard rule for a long time has been to use two different tests in a row. If both come back positive, the person is diagnosed with HIV. This two-step approach works well when the disease is common, but as the number of new infections drops, the math changes. When a disease becomes rare, even a tiny error rate in the tests can lead to more people being told they are sick when they are actually healthy. A false diagnosis is a heavy burden; it causes deep emotional distress and leads people to take life-long medication they do not need, wasting limited medical resources and shaking trust in the health system.
To solve this, the World Health Organization suggested a new rule: use three tests in a row instead of two. The idea is that adding a third check acts as a safety net, catching the rare mistakes that slip through the first two. However, changing a national health system is a massive undertaking. It costs more money, requires more supplies, and asks health workers to do extra steps. For years, many countries hesitated to make the switch, unsure if the extra cost was worth the benefit or if the new system would work smoothly in real-world conditions. They needed proof that the extra test actually prevented mistakes without breaking the bank.
A team of researchers in Malawi decided to find that proof by looking at what happened after the country made the switch. In late 2022, Malawi changed its national policy from the old two-test rule to the new three-test rule. The researchers gathered data from nearly every HIV testing site in the country, covering almost ten million visits over the next three years. They did not just watch what happened; they used a clever method to look back in time. They took the records of every single test performed under the new three-test system and asked a simple question: "If we had stopped after the second test, as we used to do, what would the result have been?" By comparing the actual three-test results with what the two-test results would have been, they could see exactly how many people would have been wrongly diagnosed under the old system.
The study revealed that the new system worked with incredible precision. Almost every single time a health worker followed the rules, the three tests were done in the correct order, and the final result was recorded properly. This high level of accuracy showed that the new system was feasible even when carried out by trained community health workers rather than just doctors. When the researchers looked at the numbers, they found that under the old two-test rule, about 1,200 people who actually tested negative on the third test would have been told they were positive. These were the "false positives" the third test was designed to catch.
To understand what happened to those 1,200 people, the researchers looked at what occurred when they returned for follow-up testing. The data showed that about 82 percent of them were eventually confirmed to be HIV-negative. This meant that the third test successfully prevented nearly 1,000 people from being misdiagnosed and starting unnecessary treatment. The researchers also looked at who was most likely to be caught in this trap. They found that people who had been tested very recently—within just one or two weeks—were much more likely to get a false positive result than those who had not been tested in a long time. This suggests that the body's immune system might still be reacting to something else, confusing the test, or that the tests themselves sometimes agree on a mistake when used in quick succession.
The final piece of the puzzle was the cost. Adding a third test to every person obviously costs more money. The researchers calculated that the extra expense for the entire country over three years was roughly 470,000 dollars. While this sounds like a lot, they compared it to the cost of treating people who do not need it. Lifelong medication for HIV is expensive, and the study estimated that by preventing nearly 1,000 unnecessary diagnoses, the country saved over 1.4 million dollars in future treatment costs over the lifetimes of those patients. When they factored in the time value of money, the extra cost of the third test paid for itself in just over seven years.
The study concludes that the switch to three tests was a smart move. It prevented nearly a thousand people from receiving a life-altering diagnosis they did not need, all while saving the health system money in the long run. The research suggests that other countries facing similar declines in HIV rates should consider making the same change. The data shows that the extra step is not just a safety measure for the patient, but also a financially sound decision for the nation. By catching the rare errors that the old system missed, Malawi protected its people from harm and its budget from waste, proving that a slightly more complex process can lead to a much better outcome.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.